|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02407 GAUSH MEDITECH
Nominal 
10.740 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 6.240% | -13.591% | -8.169% | 6.087% | -3.600% |
| ROAE (%) | 11.017% | -85.994% | N/A | N/A | 45.544% |
| Return on Capital Employed (%) | 8.889% | -15.710% | -9.592% | 10.402% | -5.955% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 49.181% | 49.876% | 46.947% | 45.337% | 41.869% |
| EBITDA Margin (%) | 26.150% | -13.666% | 0.277% | 16.780% | 1.342% |
| Pre-tax Profit Margin (%) | 17.617% | -21.941% | -10.627% | 15.503% | 0.194% |
| Net Profit Margin (%) | 12.340% | -27.885% | -14.670% | 10.328% | -3.347% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 1.560 X | 2.692 X | 2.470 X | 0.585 X | 2.327 X |
| Quick Ratio (X) | 1.191 X | 2.122 X | 1.926 X | 0.398 X | 1.846 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 40.325% | 45.304% | 126.100% | 97.862% | 106.782% |
| Total Debt / Total Assets (%) | 23.362% | 27.814% | 39.613% | 48.360% | 5.912% |
| Net Debt / Total Assets (%) | 1.606% | 1.269% | 14.517% | 34.606% | -26.425% |
| Total Debt / Shareholders' Funds (%) | 39.534% | 51.444% | N/A | 4219.364% | N/A |
| Long Term Debt / Shareholders' Funds (%) | 7.544% | 41.161% | N/A | 814.810% | N/A |
| Net Debt / Shareholders' Funds (%) | 2.717% | 2.346% | N/A | 3019.403% | N/A |
| Net Cash / (Debt) ($) | (45.663M) | (34.479M) | (352.280M) | (773.722M) | 271.921M |
| Net Cash / (Debt) per share ($) | (0.309) | (0.233) | -- | -- | -- |
| Total Debt / Capital Employed (%) | 34.034% | 33.970% | 48.416% | 113.183% | 9.781% |
| Interest Coverage Ratio (X) | 5.895 X | N/A | N/A | 49.490 X | 1.659 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 155.688 Day | 151.364 Day | 127.102 Day | 151.084 Day | 111.092 Day |
| Receivables Turnover (Day) | 40.613 Day | 48.974 Day | 47.916 Day | 69.150 Day | 63.900 Day |
| Payables Turnover (Day) | 20.669 Day | 19.901 Day | 24.240 Day | 41.299 Day | 37.367 Day |
| Remarks: | Real time quote last updated: 29/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 28,474,000 |
| %Change | -74.416% |
| EPS / (LPS) | RMB 0.190 |
| NBV Per Share (¥) | RMB 10.411 |